Related Experiment Video
Updated: Aug 16, 2026
Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans
Published on: March 24, 2022
Photodynamic therapy in the treatment of rosacea
Hanne Nybaek1, Gregor B E Jemec
1Division of Dermatology, Department of Medicine, Roskilde Hospital, Roskilde, Denmark.
Background:
Rosacea is a common disease, with an estimated prevalence of 5-10%. Established systemic and topical treatment is often effective but requires continuous medication.
Aim:
We report the outcome of photodynamic therapy (PDT) in 4 patients with rosacea.
Methods:
Prior treatment consisted of standard treatment with tetracycline and metronidazole. The treatment was however either ineffective or the patients were dissatisfied with the need for continuous treatment. The patients all received standard treatment with PDT.
Results:
The treated skin cleared in 3 of the 4 patients. Treatment with light alone did not appear to have any effect. In one of the patients there has been no relapse during a 9-month follow-up. In 2 patients, remissions lasted 3 months, during which time no additional or supplementary treatment was used.
Conclusion:
Our observation suggests that PDT may play a role in the future treatment of selected cases of rosacea.
More Related Videos
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
05:13LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
Published on: January 24, 2025